Sources | Names Used |
---|---|
CTRPv2 | Repligen 136 |
PharmacoGx | Repligen 136 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | TAS2R3 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | MPV17 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.003 |
mRNA | PRKG2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | CINP | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
mRNA | TTLL12 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | DCAF16 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
mRNA | BABAM1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
mRNA | PDCL2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | MSI1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
mRNA | TAS2R4 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |